SAM
AURA icon

Smartleaf Asset Management’s Aura Biosciences AURA Stock Holding History

Smartleaf Asset Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3K Hold
1,790
– – ﹤0.01% 2276
2026
Q1 		$11.1K Buy
1,790
+49
+3% +$281 ﹤0.01% 2276
2025
Q4 		$9.56K Buy
1,741
+478
+38% +$2.84K ﹤0.01% 2416
2025
Q3 		$7.79K Buy
1,263
+429
+51% +$2.81K ﹤0.01% 2210
2025
Q2 		$5.24K Buy
834
+183
+28% +$1.07K ﹤0.01% 2033
2025
Q1 		$4.13K Buy
651
+456
+234% +$3.45K ﹤0.01% 2255
2024
Q4 		$1.58K Buy
195
+86
+79% +$809 ﹤0.01% 2581
2024
Q3 		$984 Buy
+109
New +$935 ﹤0.01% 2661

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Smartleaf Asset Management's AURA Position: Q2 2026 in Review

Smartleaf Asset Management held its Aura Biosciences (AURA) position steady in Q2 2026 at 1,790 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2276.

Smartleaf Asset Management first reported a position in AURA in Q3 2024 and has held it in 8 quarters since. 146 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Smartleaf Asset Management held 1,790 shares of Aura Biosciences worth $12.3K as of Q2 2026.
  • Smartleaf Asset Management left its Aura Biosciences share count unchanged in Q2 2026.
  • Aura Biosciences made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2276 holding.
  • Smartleaf Asset Management first reported a position in Aura Biosciences in Q3 2024 and has held it in 8 quarters since.
  • 146 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.